文献速递甲状腺与颈部外科

单侧甲状腺乳头状癌伴侧颈淋巴结转移:全甲状腺切除与腺叶切除的系统综述与荟萃分析

Total thyroidectomy versus lobectomy for unilateral papillary thyroid cancer and lateral lymph node metastasis: A systematic review and meta-analysis.
PubMed 文献 · Surgery · 2025-12-02

该系统综述与荟萃分析比较单侧甲状腺乳头状癌伴侧颈淋巴结转移患者行腺叶切除与全甲状腺切除的疗效。纳入6项研究共1894例患者,中位随访76.9个月。腺叶切除并发症风险更低,而5年无复发生存率与复发率与全甲状腺切除相似。

要点

  • 腺叶切除总体并发症风险显著低于全甲状腺切除(RR 0.21)。
  • 腺叶切除与全甲状腺切除的5年无复发生存率及复发率无显著差异。
  • 结论需排除肉眼甲状腺外侵犯及侵袭性亚型后适用。

核心结论

  • 在排除肉眼甲状腺外侵犯和侵袭性亚型后,腺叶切除可能是单侧甲状腺乳头状癌伴侧颈淋巴结转移的首选术式,肿瘤学结局与全甲状腺切除相当且并发症更少。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Cochrane Library、Embase和Web of Science 2010至2025年文献,纳入6项研究共1894例患者,采用固定效应模型合并数据,Newcastle-Ottawa量表评估偏倚风险。

主要发现

  • 腺叶切除总体并发症风险低于全甲状腺切除(RR 0.21,95%CI 0.06-0.70,P=0.01)。

临床怎么用

  • 对于无肉眼甲状腺外侵犯且非侵袭性亚型的单侧甲状腺乳头状癌伴侧颈淋巴结转移患者,可考虑选择腺叶切除以降低并发症风险。

局限性

  • 结论需前瞻性队列研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal surgical approach for unilateral papillary thyroid cancer with lateral lymph node metastasis remains a subject of ongoing debate. This systematic review and meta-analysis aims to provide available evidence to facilitate clinical decision-making. METHODS: This study was registered in PROSPERO (CRD420251049050). Indexed databases (PubMed, The Cochrane Library, Embase, and Web of Science) were searched from 2010 to 2025 comparing lobectomy and total thyroidectomy in patients with unilateral papillary thyroid cancer and lateral lymph node metastasis. The primary outcomes include recurrence-free survival, recurrence rate, and postoperative complications. The risk of bias was assessed using the Newcastle-Ottawa Scale. Data were pooled by using the fixed-effects model. Heterogeneity was assessed using the I2 statistic and sensitivity analysis. RESULTS: Six studies with 1,894 participants were included. The mean duration of follow-up was 76.9 months. The results indicated that lobectomy has a lower risk of complications (risk ratio: 0.21, 95% confidence interval: 0.06-0.70, P = .01) compared with total thyroidectomy, especially for transient hypoparathyroidism (risk ratio: 0.01, 95% confidence interval: 0.00-0.05, P < .00001), permanent hypoparathyroidism (risk ratio: 0.06, 95% confidence interval: 0.01-0.26, P = .0002), and transient recurrent laryngeal nerve injury (risk ratio: 0.49, 95% confidence interval: 0.26-0.91, P = .02). Furthermore, lobectomy and total thyroidectomy showed similar effects on 5-year recurrence-free survival (hazard ratio: 1.03, 95% confidence interval: 0.68-1.56, P = .91) and recurrence rate (risk ratio = 1.10, 95% confidence interval: 0.77-1.58, P = .61). CONCLUSION: After excluding gross extrathyroidal extension and aggressive subtypes, this meta-analysis suggests that lobectomy is a preferred surgical approach for unilateral papillary thyroid cancer with lateral lymph node metastasis, providing comparable oncologic outcomes with significantly lower complication rates versus total thyroidectomy. Further validation through prospective cohorts is recommended.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Wu S, Zhao Y, Li H, et al. Total thyroidectomy versus lobectomy for unilateral papillary thyroid cancer and lateral lymph node metastasis: A systematic review and meta-analysis. Surgery. 2025. PMID: 41337976. doi:10.1016/j.surg.2025.109937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。